Литература

Поставить закладку

Ивашкин В.Т., Маев И.В., Лапина Т.Л. и др. Лечение инфекции Helicobacter pylori: мейнстрим и новации (Обзор литературы и резолюция Экспертного совета Российской гастроэнтерологической ассоциации 19 мая 2017 г.). Рос. Журн. гастроэнтерол гепатол колопроктол 2017; 27 (4): 4-21.
Петрова Г.В., Каприн А.Д., Грецова О.П., Старинский В.В. Злокачественные новообразования в России. Обзор статистической информации за 1993-2013 г. (под общей редакцией А.Д.Каприна и В.В.Старинского). М, 2015. 3. Malfertheiner P., Bornschein J., Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J.Dig. Dis. 2010; 11: 2-11.
Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-414.
Bornschein J., Selgrad M., Warnecke M., et al. H.pylori infection is a key risk factor for proximal gastric cancer. Dig. Dis. Sci. 2010; 55:3124-3131.
Pham T.M., Fujino Y., Kikushi S., et al. Dietary patterns and risc of stomach cancer mortality: the Japan collaborative cohort study. Ann. Epidemiol. 2016; 93 (1): 13-18.
Karimi P., Islami F., Anandasabapathy S. et al. Gastric cancer: descriptive epidemiology, risk factors, screening and prevention. Cancer Epidemiol. Biomarkers Prev. 2014; 234 (5): 700713.
Sugano K., Tack J., Kuipers E.J. et al. Kyоto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:1353-1367. 9. Malferheiner P., Megraud F., O'Morain C.A. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut 2017; 66: 6-30. 10. Song H., Ekheden I.G., Zheng Z. et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015; 351: h3867.
Пирогов С.С., Соколов В.В., Беляков М.М., Каприн А.Д. Ранний рак желудка: современный взгляд на проблему. Сибирский онкологический журнал 2017; 16 (5): 71-86.
Yaghoobi M., McNabb-Baltar J., Bijarchi R., Hunt R.H. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analisis. World J.Gastroenterol. 2017; 23 (13): 2435-2442.
Lee S.W., Chang C.S., Yeh H.J. et al. The diagnostic value of alarm features for identifying types and stages of upper gastrointestinal malignancies. Gastroenterology Res. 2017; 10 (2): 120-125.
Bizarro N., Antico A., Villa+lta D. Autoimmunity and gastric cancer. Int. J. Mol. Sci. 2018; 19 (2): 377.
Wu Y., Fan Y., Jiang Y. et al. Analysis of risk factors associated with precancerous lesion in patients from eastern China: a comparative study. J. Cancer Res,. Ther. 2013; 9 (2): 205209.
Sahovic S., Vucobrat-Bijedic Z., Sahovic V. Importance of sideropenic anemia in the diagnosis of gastrointestinal tract tumors. Mater Sociomed. 2012; 24 (2): 81-83.
Astin M.P., Martins T., Welton N. et al. Diagnostic value of symptoms of oesopgagooastric cancer in primary care: a systematic review and meta-analysis. Br. J. Gen. Pract. 2015; 65 (639): e677-691.
Yamaguchi Y., Nagata Y., Hiratsuka R., et al. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels – the ABC method. Digestion. 2016; 93 (1): 13-18.
Bang C.S., Lee J.J., Balk J.H. Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: protocol for a systemic review and metaanalysis. Medicine (Baltimore) 2019; 98 (4): e14240.
White J.R., Sami S.S., Reddiar D. et al. Narrow band imaging and serology in the assessment of premalignant gastric pathology. Scand.J.Gastroenterol. 2018; 53 (12): 1611-1618.
Zhou F., Wu L., Huang M. et al. The accuracy of magnifying narrow band imaging (ME-NBI) in distinguishing between cancerous and noncancerous gastric lesions: A metaanalysis. Medicine (Daltimore). 2018; 97 (9): e9780.
Horiguchi N., Tahara T., Kawamura T. et al. A comparative study of white light endoscopy, chromoendoscopy and magnifying endoscopy with narrow band imaging in the diagnosis of early gastric cancer after Helicobacter pylori eradication. J. Gastrointestin. Liver Dis. 2017; 26 (4): 357-362.
Zhao Z., Yin Z., Wang S. et al. Meta-analysis: The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesioins. J.Gastroenterol.Hepatol. 2016; 31 (9): 1539-1545.
Dohi O., Yagi N., Yoshida S. et al. Magnifying blue laser imaging versus magnifying narrow-band imaging for the diagnosis of early gastric cancer: a prospective, multicenter, comparative study. Digestion 2017; 96 (3): 127-134.
Dai C.L., Yang Z.G., Xue L.P. et al. Application value of multi-slice spiral computed tomography for imaging determination of metastatic lymph nodes of gastric cancer. Worls J. Gastroenterol. 2013; 19 (34): 5732-5737.
Staniuk T., Malkowski B., Srutek E. et al. Comparison of FLT-PET/CT and CECT in gastric cancer disgnosis. Abdom. Radiol (NY). 2016; 41 (7): 1349-1356.
Valero M., Robles-Medranda C. Endoscopic ultrasound in oncology: An update of clinical applications in the Gastrointestinal tract. World J. Gastrointest. Endosc. 2017; 9 (6): 243254.
Клинические рекомендации. Онкология (под ред. В.И. Чиссова, С.Л. Дарьяловой). М.: ГЭОТАР-Медиа, 2008.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница